Literature DB >> 23876474

Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies.

Sanjay Rajagopalan1, George L Bakris, William T Abraham, Bertram Pitt, Robert D Brook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23876474     DOI： 10.1161/HYPERTENSIONAHA.113.01504

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  4 in total

1.  Direct evidence of podocyte damage in cardiorenal syndrome type 2: preliminary evidence.

Authors:  Thierry H Le Jemtel; Indranee Rajapreyar; Michael G Selby; Brian Payne; David R Barnidge; Natasa Milic; Vesna D Garovic
Journal:  Cardiorenal Med       Date:  2015-02-28       Impact factor: 2.041

Review 2.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

Review 3.  New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?

Authors:  Ludovit Paulis; Romana Rajkovicova; Fedor Simko
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

4.  Reninoma: an uncommon cause of Renin-mediated hypertension.

Authors:  Peter Trnka; Luisa Orellana; Mark Walsh; Louis Pool; Peter Borzi
Journal:  Front Pediatr       Date:  2014-08-15       Impact factor: 3.418
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.